These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17986489)

  • 21. Toll-like receptors and chronic lung disease.
    Chaudhuri N; Dower SK; Whyte MK; Sabroe I
    Clin Sci (Lond); 2005 Aug; 109(2):125-33. PubMed ID: 16033327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor polymorphisms and susceptibility to human disease.
    Misch EA; Hawn TR
    Clin Sci (Lond); 2008 Mar; 114(5):347-60. PubMed ID: 18230059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll like receptors and acute allograft rejection.
    Goldstein DR
    Transpl Immunol; 2006 Dec; 17(1):11-5. PubMed ID: 17157206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity.
    Bowie AG
    Clin Exp Immunol; 2007 Feb; 147(2):217-26. PubMed ID: 17223961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate immune recognition in infectious and noninfectious diseases of the lung.
    Opitz B; van Laak V; Eitel J; Suttorp N
    Am J Respir Crit Care Med; 2010 Jun; 181(12):1294-309. PubMed ID: 20167850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate immunity and its role in type 1 diabetes.
    Zipris D
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):326-31. PubMed ID: 18594272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor heterodimer variants protect from childhood asthma.
    Kormann MS; Depner M; Hartl D; Klopp N; Illig T; Adamski J; Vogelberg C; Weiland SK; von Mutius E; Kabesch M
    J Allergy Clin Immunol; 2008 Jul; 122(1):86-92, 92.e1-8. PubMed ID: 18547625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
    Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
    Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual role of Toll-like receptors in asthma and chronic obstructive pulmonary disease.
    Bezemer GF; Sagar S; van Bergenhenegouwen J; Georgiou NA; Garssen J; Kraneveld AD; Folkerts G
    Pharmacol Rev; 2012 Apr; 64(2):337-58. PubMed ID: 22407613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLRs, NLRs and RLRs: innate sensors and their impact on allergic diseases--a current view.
    Heine H
    Immunol Lett; 2011 Sep; 139(1-2):14-24. PubMed ID: 21554901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of airway epithelial cells in development of asthma and allergic rhinitis.
    Wang Y; Bai C; Li K; Adler KB; Wang X
    Respir Med; 2008 Jul; 102(7):949-55. PubMed ID: 18339528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Toll-like receptors and the significance for clinical medicine].
    Wiersinga WJ; van der Poll T
    Ned Tijdschr Geneeskd; 2005 May; 149(21):1150-5. PubMed ID: 15940918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
    Frantz S; Ertl G; Bauersachs J
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):444-54. PubMed ID: 17653117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptors and their role in host resistance to Toxoplasma gondii.
    Yarovinsky F
    Immunol Lett; 2008 Aug; 119(1-2):17-21. PubMed ID: 18617274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
    Kanzler H; Barrat FJ; Hessel EM; Coffman RL
    Nat Med; 2007 May; 13(5):552-9. PubMed ID: 17479101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor signaling and atherosclerosis.
    Michelsen KS; Arditi M
    Curr Opin Hematol; 2006 May; 13(3):163-8. PubMed ID: 16567960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution and integration of innate immune systems from fruit flies to man: lessons and questions.
    Martinelli C; Reichhart JM
    J Endotoxin Res; 2005; 11(4):243-8. PubMed ID: 16176662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.